Patient Subgroups With a Higher Prevalence of Hypercortisolism
The panel emphasizes the importance of early identification of patients based on subgroups, such as those with difficult-to-control diabetes, hypertension, and bone issues, highlighting that the inability to lower a patient's insulin dosage is a significant risk factor for hypercortisolism.
EP: 1.Defining Resistant Diabetes
EP: 2.Differentiating Medication Non-Adherence From Underlying Comorbidities
EP: 3.Barriers to Accessing New Anti-Diabetes Medications
EP: 4.Suspecting Hypercortisolism in Patients With Resistant Diabetes
EP: 5.Testing for Hypercortisolism
Now Viewing
EP: 6.Patient Subgroups With a Higher Prevalence of Hypercortisolism
EP: 7.Evolving Perception of Autonomous Adrenal Hypercortisolism
EP: 8.Pathophysiology of Hypercortisolism
EP: 9.Need to Address Underlying Hypercortisolism
EP: 10.Approaching Treatment in Hypercortisolism
EP: 11.Choosing Between Medical and Surgical Options for Hypercortisolism
EP: 12.Long-Term Outcomes for Patients Treated for Hypercortisolism
Recent Videos
Related Content
